Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

QJM: An International Journal of Medicine

Volumn 109, Issue 6, 2016, Pages 377-382

  Berry, C ^a   Poppe, K K ^b   Gamble, G D ^b   Earle, N J ^b   Ezekowitz, J A ^c   Squire, I B ^d   McMurray, J J V ^a   McAlister, F A ^c   Komajda, M ^e,f   Swedberg, K ^g,h   Maggioni, A P ⁱ   Ahmed, A ^j,k   Whalley, G A ^l   Doughty, R N ^b   Tarantini, L ^m   Granger, C ⁿ   Kober L ⁿ   Massie, B ⁿ   Pocock, S ⁿ   Somaratne, J ⁿ   Andersson, B ⁿ   Bayes Genis, A ⁿ   Cowie, M ⁿ   Cubbon, R ⁿ   Gonzalez Juanatey, J ⁿ   Gorini, M ⁿ   Gotsman, I ⁿ   Grigorian Shamagian, L ⁿ   Guazzi, M ⁿ   Kearney, M ⁿ   Di Lenarda, A ⁿ   Lenzen, M ⁿ   Lucci, D ⁿ   Macin S ⁿ   Madsen, B ⁿ   Martinez Selles M ⁿ   Oliva, F ⁿ   Rich, M ⁿ   Richards, M ⁿ   Senni, M ⁿ   Taffet, G ⁿ   Tribouilloy, C ⁿ   Troughton, R ⁿ   Tsutsui, H ⁿ   Ariti, C ⁿ   Dobson, J ⁿ   Hall, C ⁿ   Lainchbury, J ⁿ   Hogg, K ⁿ   Norrie, J ⁿ   Stevenson, K ⁿ   Brett, M ⁿ   Pfeffer, M A ⁿ   Held, P ⁿ   Michelson, E L ⁿ   Olofsson, B ⁿ   Ostergren J ⁿ   Yusuf, S ⁿ   Torp Pedersen, C ⁿ   Scholte op Reimer, W ⁿ   Boersma, E ⁿ   Vantrimpont, P J M J ⁿ   Follath, F ⁿ   Cleland, J ⁿ   Zwas, D ⁿ   Planer, D ⁿ   Azaz Livshits, T ⁿ   Admon, D ⁿ   Lotan, C ⁿ   Keren, A ⁿ   Varela Roman, A ⁿ   Mazon Ramos P ⁿ   Rigeiro Veloso, P ⁿ   Bandin Dieguez, M A ⁿ   Myers, J ⁿ   Arena, R ⁿ   Armstrong, P W ⁿ   Cujec, Bibiana ⁿ   Paterson, Ian ⁿ   Wood, D A ⁿ   Coats, A J S ⁿ   Thompson, S G ⁿ   Suresh, V ⁿ   Poole Wilson, P A ⁿ   Sutton, G C ⁿ   Robles, J A G ⁿ   Prieto, L ⁿ   Munoa M D ⁿ   Frades, E ⁿ   Diaz Castro O ⁿ   Almendral, J ⁿ   Faggiano, P ⁿ   Bertoli, D ⁿ   Porcu, M ⁿ   Opasich, C ⁿ   Tavazzi, L ⁿ   Kirk, V ⁿ   Bay, M ⁿ   Parner, J ⁿ   Krogsgaard, K ⁿ   Herzog, T M ⁿ   Boesgaard, S ⁿ   Hassager, C ⁿ   Nielsen, O W ⁿ   Aldershvile, J ⁿ   Nielsen, H ⁿ   Kober, L ⁿ   Perna, E R ⁿ   Cimbaro Canella, J P ⁿ   Alvarenga, P ⁿ   Pantich, R ⁿ   Rios N ⁿ   Farias, E F ⁿ   Badaracco, J R ⁿ   Hansen, J F ⁿ   Stokholm, K H ⁿ   Brons, J ⁿ   Husum, D ⁿ   Mortensen, L S ⁿ   Vazquez, R ⁿ   Puig, T ⁿ   Fernandez Palomeque, C ⁿ   Bardaji A ⁿ   Pascual Figal, D ⁿ   Ordonez Llanos J ⁿ   Valdes, M ⁿ   Gabarrus, A ⁿ   Pavon, R ⁿ   Pastor, L ⁿ   Fiol, M ⁿ   Nieto, V ⁿ   Macaya, C ⁿ   Cinca, J ⁿ   Cygankiewitz, I ⁿ   Bayes De Luna, A ⁿ   Newton, J D ⁿ   Blackledge, H M ⁿ   Wright, S P ⁿ   Kerzner, R ⁿ   Gage, B F ⁿ   Freedland, K E ⁿ   Huynh, B C ⁿ   Rovner, A ⁿ   Carney, R M ⁿ   Teasdale, T A ⁿ   Bleyer, A J ⁿ   Kutka, N J ⁿ   Luchi, R J ⁿ   Rusinaru, D ⁿ   Mahjoub, H ⁿ   Souliere V ⁿ   Levy F ⁿ   Peltier, M ⁿ   Tsuchihashi, M ⁿ   Takeshita, A ⁿ   MacCarthy, P A ⁿ   Nolan, J ⁿ   Lee, A J ⁿ   Prescott, R J ⁿ   Shah, A M ⁿ   Brooksby, W P ⁿ   Fox, K A A ⁿ   Basante, P ⁿ   Trillo, R ⁿ   Garcia Seara, J ⁿ   Martinez Sande, J L ⁿ   Gude, F ⁿ   more..

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e SORBONNE UNIVERSITÉ   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ ANMCO RESEARCH CENTER   (Italy)

^j University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^k BIRMINGHAM VA MEDICAL CENTER   (United States)

^l UNITEC INSTITUTE OF TECHNOLOGY   (New Zealand)

^m UNIVERSITY OF GENOA   (Italy)

ⁿ NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; SPIRONOLACTONE;

AGED; ANEMIA; ARTICLE; DIABETES MELLITUS; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; CAUSE OF DEATH; COMPLICATION; HEART STROKE VOLUME; META ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

AGED; ANEMIA; CAUSE OF DEATH; FEMALE; HEART FAILURE; HUMANS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 84979071603     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcv087     Document Type: Article

References (29)

1. Androne A-S, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107:226-9.
2. Berry C, Norrie J, Hogg K, Brett M, Stevenson K, McMurray JJV. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J 2006; 151:1313-21.
3. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation 2003; 107:223-5.
4. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol 2008; 52:818-27.
5. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-44.
6. von Haehling S, van Veldhuisen DJ, Roughton M, Babalis D, de Boer RA, Coats AJS, et al. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results fromthe SENIORS study. Eur J Heart Fail 2011; 13:656-63.
7. Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, et al. Baseline anemia is not a predictor of allcause mortality in outpatients with advanced heart failure or severe renal dysfunction: results from the norwegian heart failure registry. J Am Coll Cardiol 2012; 59:371-8.
8. Piña I, Lin L, Weinfurt K, Isitt J, Whellan D, Schulman K, et al. Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial). Am J Cardiol 2013; 112:971-6.
9. MAGGIC Collaborative Group. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33:1750-7.
10. World Health Organization. Indicators and strategies for iron deficiency and anaemia programmes. In: Report of the WHO/UNICEF/UNU Consultation. WHO, Geneva, Switzerland, 1994.
11. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 2006; 113:986-94.
12. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-48.
13. McMurray JJV, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, et al. Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 2009; 11: 795-801.
14. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013; 368:1210-9.
15. Maurer MS, Teruya S, Chakraborty B, Helmke S, Mancini DM. Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy. Circ Heart Fail 2013; 6:254-63.
16. Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American college of physicians. Ann Intern Med 2013; 159:770-9.
17. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 2012; 33:1787-847.
18. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005; 26:2232-7.
19. Tang YD, Katz SD. Anaemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113:2454-61.
20. Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 2008; 117:526-35.
21. Chang SS, Weiss CO, Xue QL, Fried, LP. Association between inflammatory-related disease burden and frailty: results from the women's health and aging studies (WHAS) I and II. Arch Gerontol Geriatr 2012; 54:9-15.
22. Tarantini L, Oliva F, Cantoni S, Cioffi G, Agnoletto V, Alunni G, et al. Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function. Intern Emer Med 2013; 8:147-55.
23. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, et al. Anaemia and outcomes in patients with heart failure: a study from the national heart care project. Arch Intern Med 2005; 165:2237-44.
24. Russo C, Jin Z, Palmieri V, Homma S, Rundek T, Elkind MS, et al. Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertens 2012; 60:362-8.
25. Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo IJ. Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol 2013; 61:96-103.
26. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Katoh T, et al. A slightly low haemoglobin level is beneficially associated with arterial stiffness in Japanese community-dwelling women. Clin Exp Hypertens 2012; 34:92-8.
27. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. Anemia and heart failure: a community study. Am J Med 2008; 121:726-32.
28. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Circulation 2006; 113:2713-23.
29. Pocock SJ, Ariti CA, McMurray JJV, Maggioni A, Køber L, Squire IB, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013; 34: 1404-13.